The Ongoing Challenges of Understanding Long COVID and Exploring Innovative Solutions

The COVID-19 pandemic has left an indelible mark on global health, with one of the most pressing concerns being the post-acute sequelae of SARS-CoV-2 infection, commonly referred to as “Long COVID” or Post-Acute Sequelae of SARS-CoV-2 (PASC). This complex and multifaceted condition has been a topic of intense research and debate in recent years, affecting millions of Americans and creating significant burdens on healthcare systems, workplaces, and families. In this comprehensive blog post, we will delve into the epidemiology, incidence, prevalence, costs associated with Long COVID, its impact on various stakeholders, traditional treatment approaches, and innovative solutions that leverage Artificial Intelligence (AI) to combat this ongoing challenge.

Defining Long COVID: Clinical Criteria and Diagnostic Challenges
Long COVID, as defined by the US Department of Health and Human Services, encompasses signs, symptoms, and conditions present for a minimum of four weeks after initial SARS-CoV-2 infection. These symptoms may affect multiple body ...